Year | Volume (Price x Shares) | Change |
---|---|---|
2024 | $0.15 M | -87.91% |
2023 | $1.3 M | -11.11% |
2022 | $1.46 M | -59.81% |
2021 | $3.65 M | 83.41% |
2020 | $1.99 M | -21.09% |
2019 | $2.52 M | 7.7% |
2018 | $2.34 M | -79.83% |
2017 | $11.61 M | -42.62% |
2016 | $20.24 M | -32.04% |
2015 | $29.79 M | 143.14% |
2014 | $12.25 M | 3566.5% |
2013 | $0.33 M |
Company | FTD volume (3months) | FTD volume (1 year) | Country |
---|---|---|---|
Novartis NVS | $30.53 M | $95.22 M | ๐จ๐ญ Switzerland |
Pfizer PFE | $31.87 M | $0.32 B | ๐บ๐ธ USA |
Cardinal Health CAH | $47.76 M | $92.63 M | ๐บ๐ธ USA |
Jazz Pharmaceuticals JAZZ | $0.86 M | $8.12 M | ๐ฎ๐ช Ireland |
Evoke Pharma
EVOK | $0.14 M | $0.29 M | ๐บ๐ธ USA |
Celldex Therapeutics CLDX | $0.8 M | $3.83 M | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $6.66 M | $42.47 M | ๐ฎ๐ฑ Israel |
Royalty Pharma RPRX | $1.77 M | $19.5 M | ๐ฌ๐ง UK |
Lannett Company LCI | $0.39 M | $0.39 M | ๐บ๐ธ USA |